查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1169088

助眠市场：按产品类型、睡眠障碍、地区划分——规模、份额、展望、机会分析，2022-2030 年

Sleep Aids Market, by Product Type, by Sleep Disorder, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 187 Pages | 商品交期: 2-3个工作天内

价格
简介目录

助眠剂可用于治疗发作性睡病、睡眠呼吸暂停、发作性睡病、睡眠呼吸暂停、精神障碍（抑郁和焦虑）、环境问题（光线、噪音、极端温度）、医疗问题（哮喘）和其他因素。还有称为催眠药、安眠药或用于治疗各种睡眠障碍（包括失眠）的装置。 睡眠障碍的治疗包括非苯二氮卓类药物、抗抑郁药和抗精神病药。 然而，各种行为疗法，如光疗法、认知行为疗法和放鬆技巧，也可用于治疗这些疾病。 睡眠障碍是由多种疾病引起的，包括心脏病、肺病、神经系统疾病、精神疾病和抑郁症。

市场动态

市场主要参与者越来越多地采用有机策略，例如获得美国 FDA 的许可，预计将在预测期内推动市场增长。 例如，2021 年 2 月，美国 FDA 批准了一种可拆卸舌肌刺激器，这是一种为舌头提供神经肌肉刺激以减少 18 岁及以上患者打鼾和轻度睡眠呼吸暂停的新型设备，并宣布批准 eXciteOSA。 eXciteOSA 每 6 週每天使用一次，每次 20 分钟，然后停用 2 週以评估疗效。 该设备通过一个称为电肌肉刺激的过程使用适合您舌头的咬嘴来工作。

这项研究的主要特点

  • 本报告对全球助眠剂市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2030 年）内市场规模和復合年增长率 (CAGR%) 的增长情况。
  • 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
  • 它还提供重要的见解，例如市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争战略。
  • 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数介绍全球睡眠辅助设备市场主要参与者的概况。
  • 本研究涵盖的主要公司包括赛诺菲、默克公司、辉瑞公司、Koninklijke Philips N.V.、GSK plc、Sommetrics, Inc.、ResMed、Cadwell Industries, Inc.、SleepMed, Inc.、 Sci Sparc、Natus Medical Incorporated、Therapix Biosciences Ltd、Compumedics Limited、AstraZeneca、Eisai Co., Ltd.、Tris Pharma, Inc.、Novartis AG、Fisher & Paykel Healthcare Limited、Rotech Healthcare Inc.、Idorsia Pharmaceuticals Ltd.、StimScience
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。看来。
  • 本报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球睡眠辅助市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 按产品类型划分的市场概况
    • 市场概况：按睡眠障碍分类
    • 市场概况：按地区
  • 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 近期趋势
  • 收购和合作场景
  • 技术概述
  • 监管场景
  • 管道分析
  • 害虫分析

第 4 章全球安眠药市场：冠状病毒 (COVID-19) 疫情的影响

  • 总体影响
  • 对供需的影响
  • COVID-19 对市场的影响

第 5 章全球睡眠辅助市场：按产品类型，2017-2030

  • 药物
  • 床垫和枕头
  • 睡眠呼吸暂停综合征设备
  • 其他

第 6 章全球助眠剂市场：按睡眠障碍分类，2017-2030

  • 失眠
  • 睡眠呼吸暂停综合症
  • 不宁腿综合症
  • 发作性睡病
  • 恐夜症
  • 其他

第 7 章按地区分列的全球安眠药市场，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第八章竞争格局

  • Sanofi
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Koninklijke Philips N.V.
  • GSK plc.
  • Sommetrics, Inc.
  • ResMed
  • Cadwell Industries Inc.
  • SleepMed, Inc.
  • Sci Sparc
  • Natus Medical Incorporated.
  • Therapix Biosciences Ltd
  • Compumedics Limited
  • AstraZeneca
  • Eisai Co., Ltd.
  • Tris Pharma, Inc.
  • Novartis AG
  • Fisher & Paykel Healthcare Limited
  • Rotech Healthcare Inc.
  • Idorsia Pharmaceuticals Ltd
  • StimScience

第 9 章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1059

Sleeping aids, are also known as hypnotics, sleeping pills or devices used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment of sleeping disorders. However, various behavioral therapies such as light therapy, cognitive behavioral therapy, and relaxation techniques are also used in the treatment of these disorders. Sleep disorders are caused by different diseases such as heart disease, lung disease, nerve disorders, mental illness, and depression.

Market Dynamics

Increasing adoption of organic strategies by key players in market such as obtaining authorization by the U.S FDA is expected to drive market growth over the forecast period. For instance, in February 2021, the U.S. FDA announced the authorization of a novel device eXciteOSA, a removable tongue muscle stimulation device which delivers neuromuscular stimulation to the tongue to reduce snoring and mild sleep apnea for patients 18 years or older. The U.S. FDA has assessed the safety as well as effectiveness of the eXciteOSA and studied in 115 patients with snoring and mild apnea. eXciteOSA device is used for 20 minutes and once a day for every 6 weeks then discontinued for 2 weeks to study and assess the device. eXciteOSA device is reviewed through De-Novo premarket review pathway, for low to moderate risk device. It works by process called electric muscle stimulation through mouthpiece that sits around the tongue.

Key features of the study:

  • This report provides an in-depth analysis of the global Sleep Aids Market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Sleep Aids Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Sanofi, Merck & Co., Inc, Pfizer Inc., Koninklijke Philips N.V., GSK plc, Sommetrics, Inc., ResMed, Cadwell Industries, Inc., SleepMed, Inc., Sci Sparc, Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, AstraZeneca, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Fisher & Paykel Healthcare Limited, Rotech Healthcare Inc., Idorsia Pharmaceuticals Ltd., StimScience
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Sleep Aids Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sleep Aids Market

Detailed Segmentation:

  • Global Sleep Aids Market, By Product Type:
    • Medication
    • Mattresses and pillows
    • Sleep apnea devices
    • Others
  • Global Sleep Aids Market, By Sleep Disorder:
    • Insomnia
    • Sleep apnea
    • Restless legs syndrome
    • Narcolepsy
    • Night terrors
    • Others
  • Global Sleep Aids Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Sanofi
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc,
    • Pfizer Inc.,
    • Koninklijke Philips N.V.,
    • GSK plc,
    • Sommetrics, Inc.,
    • ResMed,
    • Cadwell Industries, Inc.
    • SleepMed, Inc.
    • Sci Sparc
    • Natus Medical Incorporated
    • Therapix Biosciences Ltd
    • Compumedics Limited.
    • AstraZeneca
    • Eisai Co., Ltd
    • Tris Pharma
    • Novartis AG
    • Fisher & Paykel Healthcare Limited
    • Rotech Healthcare Inc.
    • Idorsia Pharmaceuticals Ltd
    • StimScience

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Sleep Disorder
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Pipeline Analysis
  • PEST Analysis

4. Global Sleep Aids Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Sleep Aids Market, By Product Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Medication
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Mattresses and Pillows
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Sleep Apnea Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Sleep Aids Market, By Sleep Disorder, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Insomnia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Sleep Apnea
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Restless Legs Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Narcolepsy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Night Terrors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Sleep Aids Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Koninklijke Philips N.V.
  • GSK plc.
  • Sommetrics, Inc.
  • ResMed
  • Cadwell Industries Inc.
  • SleepMed, Inc.
  • Sci Sparc
  • Natus Medical Incorporated.
  • Therapix Biosciences Ltd
  • Compumedics Limited
  • AstraZeneca
  • Eisai Co., Ltd.
  • Tris Pharma, Inc.
  • Novartis AG
  • Fisher & Paykel Healthcare Limited
  • Rotech Healthcare Inc.
  • Idorsia Pharmaceuticals Ltd
  • StimScience

9. Section

  • Research Methodology
  • About Us